Metabolic benefits of Ramadan intermittent fasting revealed: key lipid changes and inflammatory marker improvements

The lipidomic changes during Ramadan diurnal intermittent fasting (RIF) among obese individuals.

FDA Panel Favors Dropping OTC Decongestant

Hundreds of allergy and cold medicines on retail shelves contain oral phenylephrine, with brands including Sudafed PE and Suphedrine PE totaling over a billion dollars

September 13, 2023

Roundups: 16 Recent Strategic Digital Health Partnerships

Walgreens and Pearl Health, a provider enablement company has announced a strategic partnership to accelerate the expansion of value-based care in collaboration with community-based primary

September 16, 2023

MindBio Therapeutics Enrolls 25th Participant into Landmark Take-Home Microdosing Depression Trial | Psychedelic Invest

Vancouver, British Columbia –TheNewswire –September 23, 2024–MindBio Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6),(the “Company” or “MindBio”),a leading biopharmaceutical company in psychiatric medicine development, is delighted to report

September 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.